Aug 2026· Reproductive Sciences· Vol 33, pp. 1816 - 1837· 0 citations· 170 references
Medicine
TL;DR
Evidence suggests that women with PMOS may be more vulnerable to selected infection-related conditions, especially vaginal dysbiosis, bacterial vaginosis, and vulvovaginal candidiasis, so clinical care should focus on established PMOS management, metabolic optimization, risk-based infection evaluation, and treatment of confirmed infections.
Recognizing PMOS as an early-life marker of cardiometabolic disease highlights opportunities for earlier diagnosis, prevention, and individualized risk stratification, supporting integrated, patient-centered care across the life course.
M. Forslund, J. Melin, A. Joham et al.· Journal of Internal Medicine· 0 citations
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders affecting women of reproductive age and represents a major global public health challenge. PCOS is a heterogeneous condition characterized by reproductive dysfunction, hyperandrogenism, insulin resistance (IR), and metabolic...
Blessy S. Joseph, D. B, K. Kumar· International Journal of Rep...· 0 citations
Effective PMOS management requires an individualized, multimodal approach that integrates lifestyle medicine with targeted supplementation and pharmacotherapy to address the complex metabolic and reproductive features of the syndrome.
Samia Bennani, Karen Foote· American Journal of Lifestyl...· 0 citations
A comprehensive and personalized therapeutic approach integrating pharmacological, lifestyle, and microbiome-targeted interventions may significantly improve PCOS management and reduce long-term metabolic and reproductive complications.
J. Singla, Shubhi Yadav, J. Gayen· Journal of Reproductive Immu...· 0 citations
It is suggested that prenatal and early postnatal environments shape gut microbiota establishment and maturation, which may interact with multiple developmental pathways and potentially modify susceptibility to PMOS later in life.
A. Kusamoto, Yutaka Osuga, Y. Hirota et al.· Reproductive Medicine and Bi...· 0 citations
Focusing on the gut-ovary axis, this review systematically summarizes the molecular mechanisms by which gut microbial metabolites mediate PCOS-related pathological processes, as well as potential intervention strategies.
Ye Gao, Lin-Lin Fan, Rui Ma et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.